HSU, SHAN HUI,徐善慧,徐善慧,TROSHIN, PAVEL ANATOLYEVICH,特罗申 帕维尔,特羅申 帕維爾,HSIEH, FU YU,谢馥羽,謝馥羽
申请号：
TW106108772
公开号：
TW201835033A
申请日:
2017.03.16
申请国别(地区):
TW
年份:
2018
代理人:
摘要：
The present invention provides a use of fullerene derivatives for the manufacture of a medicament for regulating central nervous system (CNS), wherein the fullerene derivatives includes five hydrophilic groups attached to one semisphere of the fullerene cage, and the other one remains nonfunctionalized. The fullerene derivatives of the present invention can repair CNS deficit or killing brain tumor.本發明提供一種富勒烯衍生物用於調節中樞神經系統之用途,其中該富勒烯衍生物包含5個親水性基團於半個富勒烯框架(fullerene cage)上,另一半富勒烯框架上未有任何的官能基。本發明揭露之富勒烯衍生物能夠修復中樞神經系統的損傷或是抗腦腫瘤,提供了一種新穎的腦腫瘤與神經損傷疾病之治療方式。
